Advertisement

Topics

Atrial Fibrillation and WolffParkinsonWhite Syndrome WPW - Biotech, Pharma and Life Science Channel

09:18 EDT 29th March 2017 | BioPortfolio

PubMed Articles [8450 Associated PubMed Articles listed on BioPortfolio]

The relationship between right-to-left shunt and brain white matter lesions in Japanese patients with migraine: a single center study.

There may be a link between right-to-left shunt (RLs) and brain white matter lesions (WMLs) in patients with migraine. In this study, we assessed the relationship between WMLs and RLs in Japanese migr...

Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: a prospective descriptive study.

Despite few studies, a monitoring of a neuromuscular blockade with a train of four (TOF) is recommended in intensive care unit (ICU). Our objective was to compare the results of ulnar and facial TOF m...

Neuroprotective and Therapeutic Effect of Caffeine on the Rat Model of Parkinson's Disease Induced by Rotenone.

The present study aimed to investigate the protective and therapeutic effects of caffeine on rotenone-induced rat model of Parkinson's disease (PD). Rats were divided into control, PD model induced by...

Vasopressors induce passive pulmonary hypertension by blood redistribution from systemic to pulmonary circulation.

Vasopressors are widely used in resuscitation, ventricular failure, and sepsis, and often induce pulmonary hypertension with undefined mechanisms. We hypothesize that vasopressor-induced pulmonary hyp...

White-coat hypertension is a risk factor for cardiovascular diseases and total mortality.

Whether white-coat hypertension (WCH) is an innocent phenomenon is controversial.

Disseminated peripheral neuroblastoma in a Rhodesian Ridgeback dog.

A 4-year-old neutered male Rhodesian Ridgeback dog with right-sided Horner's syndrome, bilateral laryngeal paralysis, neck pain and bilateral hindlimb ataxia was euthanased following deterioration of ...

Expansion of the phenotypic spectrum in three families of methyl CpG-binding protein 2 duplication syndrome.

The methyl CpG-binding protein 2 duplication syndrome (OMIM #300260) is characterized by hypotonia, developmental delay, spasticity, seizures, and recurrent infections. It is fully penetrant in males ...

Chemotherapy-related acute respiratory distress syndrome in germ cell tumors: a literature review.

Germ cell tumors (GCTs) are one of the more curable solid cancers in men. Approximately 8500 men are diagnosed with GCTs in the USA. The majority of patients survive due to the availability of effecti...

Locked-in Syndrome Due to Transtentorial Herniation and Kernohan Notch Phenomenon.

Key insights into the protein tyrosine phosphatase PTPN11/SHP2 associated with noonan syndrome and cancer.

News Articles [3861 Associated News Articles listed on BioPortfolio]

EnableSoft Inc. Releases White Paper Offering Advice to Improve Revenue Cycle Management

New white paper highlights ways industry can remove bottlenecks, increase efficiency EnableSoft Inc., a provider of Robotic Process Automation (RPA) software for ...

X4 Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference

X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 inhibitor drugs to improve immune cell trafficking to treat cancer and rare disease, today announ...

Innoviva Board Sends Letter to Shareholders

Board Recommends Innoviva Shareholders Support the Company’s Strategy and Board, which has Delivered Strong Returns Recommends Shareholders Vote “FOR” All of Innovi...

ALCOOL : Sa consommation modérée réduit certains risques cardiovasculaires - BMJ

L'abus d'alcool entraîne un risque accru de fibrillation auriculaire, de crise cardiaque ou d'insuffisance cardiaque c'est connu. Ce qui ne l'était pas est que l'alcool peut être un...

Acorda Announces Long-Term Safety Data for CVT-301

Pulmonary function measures over 12 months comparable between CVT-301 and observational control group Separate clinical studies assessed safety profile o...

STAT Plus: That $1.2b cut to the NIH this year? Going nowhere, key GOP Congressman says

The $1.2 billion cut to the National Institutes of Health’s 2017 budget, proposed today by the White House, seems like a nonstarter in Congress.

Drug developer Faron Pharmaceuticals' annual results statement charts a year of major landmarks

The annual results statement from Faron Pharmaceuticals Ltd (LON:FARN) charted a period of progress and success with its main drug candidate. Traumakine, used to treat acute respiratory distress syn...

Intec Pharma Provides Update on Phase III ACCORDANCE Study of the Accordion Pill Carbidopa/Levodopa in Parkinson's Disease Patients

JERUSALEM, March 29, 2017 /PRNewswire/ -- Intec Pharma Ltd. (Nasdaq; TASE: NTEC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ ...

BergaMet NA Products Available for Purchase on RevNutrition.com

BergaMet NA, a company known for developing products that help improve symptoms of metabolic syndrome, announced its products are now available for purchase on RevNutrition.com, a popular website for ...

Atypical Hemolytic Uremic Syndrome Nondiarrhea Associated Hemolytic Uremic Syndrome Pipeline Review, H1 2017 [Updated: 28022017] Prices from USD $2000

Atypical Hemolytic Uremic Syndrome Nondiarrhea Associated Hemolytic Uremic Syndrome Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide ...

Events [0 Results]

None

Companies [157 Associated Companies listed on BioPortfolio]

MedAutonomic

MedAutonomic is a privately held medtech company dedicated to developing a bioelectric medicine to treat patients with functional diseases of the metabolic syndrome such as type-2...

Population Bio

Population Bio, Inc. (PB) is a privately held global gene discovery company leading the field of precision medicine. Built on extensive intellectual property, PB is empowering pha...

Ironwood Pharmaceuticals, Inc. & Astellas Pharma Inc.

Ironwood Pharmaceuticals (NASDAQ: IRWD) is a commercial biotechnology company focused on creating medicines that make a difference for patients, building value for our fellow shar...

XenoPort

We are a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates for the potential treatment of central nervous system (CNS) disorders. We also have a p...

King-Devick Test, Inc.

King-Devick Test is used worldwide as a proven indicator of saccadic eye movements as they relate to reading, using Rapid Number Naming. Elite neurological journals have called th...

LuxCath LLC

LuxCath is a leader in catheter-based, real-time, optical tissue-electrode contact assessment, lesion progression monitoring, and lesion visualization for cardiac ablation. LuxCat...

Velicept Therapeutics, Inc.

Velicept Therapeutics, Inc. is a privately held, clinical development company focused on advancing best-in-class compounds with the potential to fill unmet medical needs. Its lead...

Alexion Pharmaceuticals Inc.

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed ...

Prana Biotechnology

Prana Biotechnology has developed a proprietary library of class-leading chemical compounds. This library is combined with a drug development program to explore novel therapeutics in multiple disease ...

PathMaker Neurosystems Inc.

PathMaker Neurosystems Inc. is a clinical-stage neuromodulation company founded to commercialize recent breakthrough advances in the development and clinical application of trans-...

Clinical Trials [5191 Associated Clinical Trials listed on BioPortfolio]

Skin Barrier Biophysical Properties and Clinical Appearance After Moisturizer in Dry Skin

The purpose of the study is to compare the changes in the appearance of dry skin after the use various moisturizers: white petrolatum ointment, coconut oil, jojoba oil, and almond oil in p...

Pilot Atrial Fibrillation Information Technology Trial

AF is associated with significant social and medical costs, including diminished quality of life (QOL) and increased health care utilization (HCU). This pilot study will enroll 200 adults ...

Genetics of Ehlers-Danlos Syndrome

We are planning to collected blood and saliva for DNA extraction to use for genetic testing of children and adults with EDS and their relatives. Medical records from other institutions and...

Tolerability and Steady-state Pharmacokinetics of BIA 6-512

To investigate the tolerability and safety of four multiple-dose regimens of BIA 6-512 (25 mg, 50 mg, 100 mg, and 150 mg 6 times daily) in healthy volunteers and to characterise the steady...

Termination Therapy for Ventricular Tachyarrhythmias

This observation study evaluates the safety and effectiveness of UPT therapy in subjects during either an indicated ventricular tachycardia ablation procedure or an ICD implant procedure.

Proper Extent of Maze Intercaval Lesion

It's hypothesized that a mean and range distance from the cavo-atrial junction to the area where there is complete loss of conductive tissue can be measured to better inform surgeons perfo...

CArdioSurgEry Atrial Fibrillation Register

CASE AF aims to describe the reality of medical care of patients in whom atrial fibrillation is treated by cardiac surgical ablation.

Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics

To investigate the effect of four single oral doses of BIA 6-512 (25 mg, 50 mg, 100 mg and 200 mg) on levodopa pharmacokinetics when administered in combination with a single-dose of contr...

The Efficacy and Safety of the Xu-Fu-Zhu-Yu Capsule in Treatment of Qi Stagnation and Blood Stasis Syndrome.

This is a muticenter, double-blind, randomized and placebo-controled trial. the purpose of this trial is to evaluate the efficacy and safety of the Xu-Fu-Zhu-Yu Capsule in Treatment of Qi ...

PLUG Dementia Trial

Patients will be screened at Intermountain Medical Center and at Intermountain affiliated anticoagulation clinics in the Salt Lake City region. Patients with atrial fibrillation that under...

Videos

None available.

Medical and Biotech [MESH] Definitions

A form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulse conducts to the HEART VENTRICLES via an accessory pathway located between the wall of the right or left atria and the ventricles, known as the bundle of Kent. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.

Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES).

A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)

Recording of regional electrophysiological information by analysis of surface potentials to give a complete picture of the effects of the currents from the heart on the body surface. It has been applied to the diagnosis of old inferior myocardial infarction, localization of the bypass pathway in Wolff-Parkinson-White syndrome, recognition of ventricular hypertrophy, estimation of the size of a myocardial infarct, and the effects of different interventions designed to reduce infarct size. The limiting factor at present is the complexity of the recording and analysis, which requires 100 or more electrodes, sophisticated instrumentation, and dedicated personnel. (Braunwald, Heart Disease, 4th ed)

A condition caused by dysfunctions related to the SINOATRIAL NODE including impulse generation (CARDIAC SINUS ARREST) and impulse conduction (SINOATRIAL EXIT BLOCK). It is characterized by persistent BRADYCARDIA, chronic ATRIAL FIBRILLATION, and failure to resume sinus rhythm following CARDIOVERSION. This syndrome can be congenital or acquired, particularly after surgical correction for heart defects.

Quick Search
Advertisement
 
review and buy Atrial Fibrillation and WolffParkinsonWhite Syndrome WPW market research data and corporate reports here

Channels Quicklinks